| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $6.59 ▼ -4.49% | Yesterday | $6.90 • 0.00% | Tomorrow's Sagimet Biosciences Inc. Series A Common Stock (SGMT) setup is anchored to $6.90 and targets $6.59 (-4.49%). The near-term read is downside; watch $7.23 / $6.57 because daily realized volatility is about 5.16%. |
Tomorrow's Sagimet Biosciences Inc. Series A Common Stock (SGMT) setup is anchored to $6.90 and targets $6.59 (-4.49%). The near-term read is downside; watch $7.23 / $6.57 because daily realized volatility is about 5.16%. | ||||
| Week | $6.39 ▼ -7.39% | Last Week | $6.90 • 0.00% | The 7-day Sagimet Biosciences Inc. Series A Common Stock model moves from $6.90 to $6.39 (-7.39%). It gives downside momentum context for this stock, so breaks around $7.23 / $6.57 matter more than a single tick. |
The 7-day Sagimet Biosciences Inc. Series A Common Stock model moves from $6.90 to $6.39 (-7.39%). It gives downside momentum context for this stock, so breaks around $7.23 / $6.57 matter more than a single tick. | ||||
| Month | $6.70 ▼ -2.90% | Last Month | $6.90 • 0.00% | The 1-month Sagimet Biosciences Inc. Series A Common Stock target is $6.70 (-2.90%), compared with the live reference near $6.90. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Sagimet Biosciences Inc. Series A Common Stock target is $6.70 (-2.90%), compared with the live reference near $6.90. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $7.33 ▲ +6.23% | Last Year | $6.90 • 0.00% | The 1-year Sagimet Biosciences Inc. Series A Common Stock scenario points to $7.33 (+6.23%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Sagimet Biosciences Inc. Series A Common Stock scenario points to $7.33 (+6.23%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $8.69 ▲ +25.94% | 5 Years Ago | $6.90 • 0.00% | The 5-year Sagimet Biosciences Inc. Series A Common Stock view is $8.69 (+25.94%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Sagimet Biosciences Inc. Series A Common Stock view is $8.69 (+25.94%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| RSI 14 | 54.2 | Neutral |
| MACD | -0.10 | Bearish |
| SMA 50 | $6.73 | Mid |
| SMA 200 | $6.79 | Mid |
| EMA 20 | $6.74 | Mid |
| Opening Price | $6.90 | Start Date | 2021-05-17 |
| Day Range | $6.67 – $7.13 | Market Cap | $192.58M |
| Monthly Range | $6.28 – $7.33 | 24h Volume | n/a |
| 90D Range | $6.15 – $7.47 | Circulating | n/a |
| 52W Range | $6.15 – $8.12 | Max Supply | n/a |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.